ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25D16694
Home | Market Reports | Health| Health Foundations & Medical Research
Global Human Induced Pluripotent Stem Cells iPSCs Market Research Report 2024
BUY CHAPTERS

Global Human Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2025

Code: QYRE-Auto-25D16694
Report
September 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fujifilm Cellular Dynamics
Takara Bio
Thermo Fisher Scientific
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma
Fate Therapeutics
Cell Inspire Biotechnology
Reprocell
AcceGen

Human Induced Pluripotent Stem Cells (iPSCs) Market Size

The global market for Human Induced Pluripotent Stem Cells (iPSCs) was valued at US$ 134 million in the year 2024 and is projected to reach a revised size of US$ 425 million by 2031, growing at a CAGR of 18.2% during the forecast period.

Human Induced Pluripotent Stem Cells (iPSCs) Market

Human Induced Pluripotent Stem Cells (iPSCs) Market

Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
North American market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Human Induced Pluripotent Stem Cells (iPSCs) include FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Induced Pluripotent Stem Cells (iPSCs).
The Human Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Induced Pluripotent Stem Cells (iPSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Induced Pluripotent Stem Cells (iPSCs) Market Report

Report Metric Details
Report Name Human Induced Pluripotent Stem Cells (iPSCs) Market
Accounted market size in year US$ 134 million
Forecasted market size in 2031 US$ 425 million
CAGR 18.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Skin
  • Blood
  • Others
Segment by Application
  • Academic Research
  • Drug Development and Discovery
  • Toxicity Screening
  • Regenerative Medicine
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Induced Pluripotent Stem Cells (iPSCs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Induced Pluripotent Stem Cells (iPSCs) Market growing?

Ans: The Human Induced Pluripotent Stem Cells (iPSCs) Market witnessing a CAGR of 18.2% during the forecast period 2025-2031.

What is the Human Induced Pluripotent Stem Cells (iPSCs) Market size in 2031?

Ans: The Human Induced Pluripotent Stem Cells (iPSCs) Market size in 2031 will be US$ 425 million.

Who are the main players in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The main players in the Human Induced Pluripotent Stem Cells (iPSCs) Market are FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology, ReproCELL, AcceGen

What are the Application segmentation covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Applications covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Types covered in the Human Induced Pluripotent Stem Cells (iPSCs) Market report are Skin, Blood, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Skin
1.2.3 Blood
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2020-2031)
2.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
2.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2020-2025)
2.2.3 Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2026-2031)
2.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
2.3.1 Human Induced Pluripotent Stem Cells (iPSCs) Industry Trends
2.3.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers
2.3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges
2.3.4 Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue
3.1.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2020-2025)
3.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2020-2025)
3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Induced Pluripotent Stem Cells (iPSCs) Revenue
3.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
3.4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2024
3.5 Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs) Head office and Area Served
3.6 Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs), Product and Application
3.7 Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type
4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2020-2025)
4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2026-2031)
5 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application
5.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2020-2025)
5.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
6.2 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
6.4 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
7.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
8.2 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
9.2 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
9.4 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2020-2031)
10.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Cellular Dynamics
11.1.1 FUJIFILM Cellular Dynamics Company Details
11.1.2 FUJIFILM Cellular Dynamics Business Overview
11.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.1.4 FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.1.5 FUJIFILM Cellular Dynamics Recent Development
11.2 Takara Bio
11.2.1 Takara Bio Company Details
11.2.2 Takara Bio Business Overview
11.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.2.4 Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.2.5 Takara Bio Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.3.4 Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Ncardia
11.4.1 Ncardia Company Details
11.4.2 Ncardia Business Overview
11.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.4.4 Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.4.5 Ncardia Recent Development
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Details
11.5.2 Sumitomo Dainippon Pharma Business Overview
11.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.5.4 Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.5.5 Sumitomo Dainippon Pharma Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.6.4 Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.6.5 Astellas Pharma Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.7.4 Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.7.5 Fate Therapeutics Recent Development
11.8 Cell Inspire Biotechnology
11.8.1 Cell Inspire Biotechnology Company Details
11.8.2 Cell Inspire Biotechnology Business Overview
11.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.8.4 Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.8.5 Cell Inspire Biotechnology Recent Development
11.9 ReproCELL
11.9.1 ReproCELL Company Details
11.9.2 ReproCELL Business Overview
11.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.9.4 ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.9.5 ReproCELL Recent Development
11.10 AcceGen
11.10.1 AcceGen Company Details
11.10.2 AcceGen Business Overview
11.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.10.4 AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
11.10.5 AcceGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Fujifilm Cellular Dynamics
Takara Bio
Thermo Fisher Scientific
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma
Fate Therapeutics
Cell Inspire Biotechnology
Reprocell
AcceGen
List of Tables
 Table 1. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Skin
 Table 3. Key Players of Blood
 Table 4. Key Players of Others
 Table 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2020-2025)
 Table 9. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2026-2031)
 Table 11. Human Induced Pluripotent Stem Cells (iPSCs) Market Trends
 Table 12. Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers
 Table 13. Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges
 Table 14. Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints
 Table 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2020-2025)
 Table 17. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2024)
 Table 18. Ranking of Global Top Human Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs), Headquarters and Area Served
 Table 21. Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs), Product and Application
 Table 22. Global Key Players of Human Induced Pluripotent Stem Cells (iPSCs), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2020-2025)
 Table 26. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2026-2031)
 Table 28. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2020-2025)
 Table 30. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2026-2031)
 Table 32. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. FUJIFILM Cellular Dynamics Company Details
 Table 48. FUJIFILM Cellular Dynamics Business Overview
 Table 49. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 50. FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 51. FUJIFILM Cellular Dynamics Recent Development
 Table 52. Takara Bio Company Details
 Table 53. Takara Bio Business Overview
 Table 54. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 55. Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 56. Takara Bio Recent Development
 Table 57. Thermo Fisher Scientific Company Details
 Table 58. Thermo Fisher Scientific Business Overview
 Table 59. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 60. Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 61. Thermo Fisher Scientific Recent Development
 Table 62. Ncardia Company Details
 Table 63. Ncardia Business Overview
 Table 64. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 65. Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 66. Ncardia Recent Development
 Table 67. Sumitomo Dainippon Pharma Company Details
 Table 68. Sumitomo Dainippon Pharma Business Overview
 Table 69. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 70. Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 71. Sumitomo Dainippon Pharma Recent Development
 Table 72. Astellas Pharma Company Details
 Table 73. Astellas Pharma Business Overview
 Table 74. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 75. Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 76. Astellas Pharma Recent Development
 Table 77. Fate Therapeutics Company Details
 Table 78. Fate Therapeutics Business Overview
 Table 79. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 80. Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 81. Fate Therapeutics Recent Development
 Table 82. Cell Inspire Biotechnology Company Details
 Table 83. Cell Inspire Biotechnology Business Overview
 Table 84. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 85. Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 86. Cell Inspire Biotechnology Recent Development
 Table 87. ReproCELL Company Details
 Table 88. ReproCELL Business Overview
 Table 89. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 90. ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 91. ReproCELL Recent Development
 Table 92. AcceGen Company Details
 Table 93. AcceGen Business Overview
 Table 94. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product
 Table 95. AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025) & (US$ Million)
 Table 96. AcceGen Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Human Induced Pluripotent Stem Cells (iPSCs) Picture
 Figure 2. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2024 VS 2031
 Figure 4. Skin Features
 Figure 5. Blood Features
 Figure 6. Others Features
 Figure 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2024 VS 2031
 Figure 9. Academic Research Case Studies
 Figure 10. Drug Development and Discovery Case Studies
 Figure 11. Toxicity Screening Case Studies
 Figure 12. Regenerative Medicine Case Studies
 Figure 13. Others Case Studies
 Figure 14. Human Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
 Figure 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2024 VS 2031
 Figure 18. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2024
 Figure 19. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2024
 Figure 21. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
 Figure 23. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
 Figure 27. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2020-2031)
 Figure 35. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
 Figure 43. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2020-2031)
 Figure 47. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. FUJIFILM Cellular Dynamics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 51. Takara Bio Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 53. Ncardia Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 54. Sumitomo Dainippon Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 55. Astellas Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 56. Fate Therapeutics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 57. Cell Inspire Biotechnology Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 58. ReproCELL Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 59. AcceGen Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Induced Pluripotent Stem Cells iPSCs Culture Medium Market Research Report 2024
Global Induced Pluripotent Stem Cells iPSCs Market Insights Forecast to 2030
Global iPSC Generation Kit Market Research Report 2025
Global iPSC Kit Market Research Report 2025
Global Induced Pluripotent Stem Cells Service Market Research Report 2024
Global iPSC Cell Therapies Market Research Report 2025
Global iPSC Differentiation Kit Market Research Report 2025
Global IPS Cell Differentiation Kit Market Research Report 2025
Global iPSC Characterization Kit Market Research Report 2025
Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025
Global iPSCs Expansion Medium Market Research Report 2024
Global Human iPS Cell Characterization Kit Market Research Report 2025
Global Induced Pluripotent Stem Cells Production Market Research Report 2025
Global Stem Cell Research Antibodies Market Research Report 2024
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Global IPS Cell derived Platelets Market Research Report 2025
Global Mouse Embryonic Stem Cell Market Research Report 2024
Cell Transplant Market
Global Regenerative Cell Market Research Report 2024
Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions